These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1663595)
1. Biochemical and behavioral studies following subchronic administration of GABA uptake inhibitors in mice. Karbon EW; Enna SJ; Ferkany JW Neuropharmacology; 1991 Nov; 30(11):1187-92. PubMed ID: 1663595 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake. Löscher W Eur J Pharmacol; 1985 Mar; 110(1):103-8. PubMed ID: 4007046 [TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. Yunger LM; Fowler PJ; Zarevics P; Setler PE J Pharmacol Exp Ther; 1984 Jan; 228(1):109-15. PubMed ID: 6694095 [TBL] [Abstract][Full Text] [Related]
4. Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain. Bonanno G; Raiteri M Br J Pharmacol; 1987 May; 91(1):237-43. PubMed ID: 3594080 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the anticonvulsant effects of two novel GABA uptake inhibitors and diazepam in amygdaloid kindled rats. Schwark WS; Löscher W Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):367-71. PubMed ID: 4033806 [TBL] [Abstract][Full Text] [Related]
6. Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine. Larsson OM; Falch E; Krogsgaard-Larsen P; Schousboe A J Neurochem; 1988 Mar; 50(3):818-23. PubMed ID: 3339356 [TBL] [Abstract][Full Text] [Related]
7. Presence of a gamma-aminobutyric acid (GABA) uptake system on cholinergic terminals of rat hippocampus: evidence for neuronal coexistence of acetylcholine and GABA? Bonanno G; Raiteri M J Pharmacol Exp Ther; 1987 Jan; 240(1):294-7. PubMed ID: 3806391 [TBL] [Abstract][Full Text] [Related]
8. GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs. Zorn SH; Enna SJ Life Sci; 1985 Nov; 37(20):1901-12. PubMed ID: 4058259 [TBL] [Abstract][Full Text] [Related]
9. Increased inhibition in dentate gyrus granule cells following exposure to GABA-uptake blockers. Albertson TE; Joy RM Brain Res; 1987 Dec; 435(1-2):283-92. PubMed ID: 3427456 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of excitotoxic cell swelling and GABA release by the GABA transport inhibitor SKF 89976A. Zeevalk GD; Nicklas WJ Mol Chem Neuropathol; 1996 Sep; 29(1):27-36. PubMed ID: 8887938 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic tiagabine treatment on [3H]GABAA, [3H]GABAB and [3H]tiagabine binding to sections from mice brain. Thomsen C; Suzdak PD Epilepsy Res; 1995 Jun; 21(2):79-88. PubMed ID: 7588591 [TBL] [Abstract][Full Text] [Related]
12. Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Pittaluga A; Asaro D; Pellegrini G; Raiteri M Eur J Pharmacol; 1987 Nov; 144(1):45-52. PubMed ID: 2830119 [TBL] [Abstract][Full Text] [Related]
13. Depolarization by K+ and glutamate activates different neurotransmitter release mechanisms in GABAergic neurons: vesicular versus non-vesicular release of GABA. Belhage B; Hansen GH; Schousboe A Neuroscience; 1993 Jun; 54(4):1019-34. PubMed ID: 8101980 [TBL] [Abstract][Full Text] [Related]
17. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate. Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates. Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872 [TBL] [Abstract][Full Text] [Related]
19. GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Dalby NO Neuropharmacology; 2000 Sep; 39(12):2399-407. PubMed ID: 10974324 [TBL] [Abstract][Full Text] [Related]
20. Cholinergic nerve terminals of human cerebral cortex possess a GABA transporter whose activation induces release of acetylcholine. Bonanno G; Ruelle A; Andrioli GC; Raiteri M Brain Res; 1991 Jan; 539(2):191-5. PubMed ID: 2054596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]